TEXT ABOUT HCP PORTAL
Add text here
ed si ille hac tam eximia fortuna propter utilitatem rei publicae frui non properat, ut omnia illa conficiat, quid ego, senator, facere debeo, quem, etiamsi ille aliud vellet, rei publicae consulere oporteret?
Tu autem, Fanni, quod mihi tantum tribui dicis quantum ego nec adgnosco nec postulo, facis amice; sed, ut mihi videris, non recte iudicas de Catone; aut enim nemo, quod quidem magis credo, aut si quisquam, ille sapiens fuit. Quo modo, ut alia omittam, mortem filii tulit! memineram Paulum, videram Galum, sed hi in pueris, Cato in perfecto et spectato viro.
Quo cognito Constantius ultra mortalem modum exarsit ac nequo casu idem Gallus de futuris incertus agitare quaedam conducentia saluti suae per itinera conaretur, remot
Explore more
Filter
Disease Areas
Filter by
recent search
Showing: 1 – 05 of 12 Product
Bylvay® (odevixibat)
Bylvay is a non-systemic ileal bile acid transport inhibitor (IBATi), that treats Progressive Familial Intrahepatic Cholestasis (PFIC) and other rare cholestatic diseases in children
Cabometyx® (cabozantinib)
A tyrosine kinase inhibitor (TKI) used in the treatment of advanced kidney cancer (advanced renal cell carcinoma – aRCC) as monotherapy or in combination with nivolumab. It is also indicated in adults living with liver cancer (hepatocellular carcinoma) previously treated with the medicine sorafenib. In the E.U., it is also indicated for the treatment of adults with locally advanced or metastatic differentiated thyroid carcinoma (DTC), who are refractory or not eligible to radioactive iodine and who have progressed after prior systemic therapy.
Cometriq® (cabozantinib)
A tyrosine kinase inhibitor (TKI) used to treat people with progressive, unresectable or locally advanced medullary thyroid cancer (MTC) or MTC that has spread to other parts of the body (metastatic MTC).
Decapeptyl® (triptorelin pamoate or acetate)
An analog of the natural gonadotropin-releasing hormone (GnRH), halting the production of sexual hormones. It is approved for the treatment of high-risk localized, locally advanced or metastatic prostate cancer, endometriosis, uterine fibroids and central precocious puberty (CPP). It is also approved as an adjuvant treatment in combination with tamoxifen or an aromatase inhibitor for women at high risk of recurrence of endocrine-responsive early-stage breast cancer. It is also used to induce ovulation for in vitro fertilization.
Dysport® (abobotulinumtoxinA)
An acetylcholine release inhibitor and a neuromuscular blocking agent, Dysport contains a toxin produced by the bacterium Clostridium botulinum indicated for symptomatic treatment of focal spasticity of the upper and lower limbs in adults and children over two years old.
It is also indicated for adults for symptomatic treatment of:
- Spasmodic torticollis (cervical dystonia)
- Blepharospasm
- Hemifacial spasm
- Severe primary hyperhidrosis of the axillae
Also used for the temporary improvement in the appearance of moderate to severe glabellar and lateral canthal lines associated with procerus and corrugator muscle activity in adults under 65.